Hypersensitivity reactions to ophthalmic products
Department of Internal Medicine, Immunology and Infectious Diseases, University of Bari, Policlinico, Piazza G. Cesare no 11, 70124 Bari, Italy.Current pharmaceutical design (Impact Factor: 3.45). 02/2006; 12(26):3401-10. DOI: 10.2174/138161206778194024
Adverse reactions after administration of ophthalmic products have frequently been observed. These reactions can be provoked by both active principles and excipients. Different pathogenic mechanisms have been suggested for such reactions, including immunologic ones. Basophils and mast cells participate in IgE-mediated reactions through the release of mediators like histamine and tryptase, whereas a T-cell-mediated pathogenic mechanism is involved in most delayed reactions, particularly conjunctival ones and eyelid dermatitis. Prick tests and immediate-reading intradermal tests are carried out to diagnose immediate hypersensitivity reactions, while patch tests are usually performed to evaluate delayed reactions. Other diagnostic tests, such as serum-specific IgE assays in immediate reactions, as well as delayed-reading intradermal tests and/or lymphocyte transformation tests in delayed ones, are rarely performed. In this review, particular attention is addressed to the clinical and practical aspects of both cell-mediated and IgE-mediated hypersensitivity reactions to ophthalmic products.
Conference Paper: Design of decentralized adaptive controllers[Show abstract] [Hide abstract]
ABSTRACT: The control of a class of large scale systems formed by an arbitrary linear interconnection of linear time-invariant subsystems with unknown parameters is investigated. An approach is developed for stabilization and tracking using decentralized adaptive controllers. Sufficient conditions are established in a form of algebraic criteria which can guarantee desired stability properties under certain structural perturbations.Decision and Control, 1983. The 22nd IEEE Conference on; 01/1984
- European journal of dermatology: EJD 01/2009; 19(1):74-5. DOI:10.1684/ejd.2008.0548 · 1.99 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Identifying contact allergens in ophthalmic medications can be a challenging and daunting experience. We summarize data on topical ophthalmic medications with the potential to cause periorbital contact dermatitis and allergic conjunctivitis, highlighting current dilemmas and controversies in this area. The following groups of allergens are reviewed: preservatives, antiglaucoma medications (prostaglandin analogues, β-blockers, carbonic anhydrase inhibitors, parasympathomimetics, sympathomimetics), antiinflammatory medications (nonsteroidal antiinflammatory drugs, corticosteroids), antibiotics, antivirals, antiallergic medications (antihistamines, cromones), anaesthetics, mydriatics, and cycloplegics.Clinics in dermatology 05/2011; 29(3):295-9. DOI:10.1016/j.clindermatol.2010.11.008 · 2.47 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.